Peijia Medical (FRA:4WO) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4WO Peijia Medical Ltd FRA:4WO
74 GF Score
Price €0.42
GF Value €0.85
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Peijia Medical Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:4WO
74GF Score
Peijia Medical Ltd FRA:4WO
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Peijia Medical (FRA:4WO) Overvalued in 2026?

Based on GuruFocus' analysis, Peijia Medical stock appears to be undervalued. The current stock price of €0.42 is trading 50.4% below its estimated GF Value™ of €0.85. GuruFocus considers Peijia Medical to be Possible Value Trap.

Key valuation signals for FRA:4WO:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €0.85 vs. price of €0.42 (50.4% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the FRA:4WO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Peijia Medical Business Description

Other Exchanges 09996:Hong Kong4WO:Germany
Address No.18 Yangjiatian Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
74GF Score

Get the complete analysis for FRA:4WO

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.42
Price
€0.85
GF Value